The risk of ovarian malignancy algorithm (ROMA) is a predictive tool that can evaluate the probability and prognosis of epithelial ovarian cancer, calculated by combining the measured values of CA125 and HE4 levels in the blood (Kim et al., 2019). The gene discussed is WFDC2; the disease is ovarian carcinoma.